TrialAnnals of clinical and translational neurology2020

Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy.

Hirofumi Komaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.